2024
ECCO | European Crohns and Colitis Organisation
Seneste nytt fra ECCO 2024
2023
Can We Improve the Quality of Care in Inflammatory Bowel Disease?
/ Liselotte Fierens
Physiological Hypoxia Improves Growth and Differentiation of Human Colonoids
/ Gunnar Andreas Walaas
Significantly Higher Risk of Surgery in Inflammatory Bowel Disease for Men
/ Nathalie Fogh Rasmussen
A New Potential Clinical Marker for Extraintestinal Manifestations in IBD
/ Ignacio Catalan-serra
No Altered Risk of IBD Associated with the Overall Use of GLP-1 Based Therapies
/ Heidi Søgaard Christensen
Positive Results with Filgotinib for Ulcerative Colitis from ECCO23
/ BestPractice Nordic
Upadacitinib Benefits Ulcerative Colitis Patients – ECCO23 Data
/ BestPractice Nordic